Incannex Healthcare (IXHL) Current Assets (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Current Assets of $80.1 million for Q1 2026, up 412.48% year-on-year from $15.6 million in Q1 2025, and up 7.25% on a QoQ basis from $74.7 million in Q4 2025.

Incannex Healthcare (IXHL) Current Assets (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Current Assets for 7 consecutive years, with $80.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Current Assets rose 412.48% year-over-year to $80.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.1 million (up 412.48% YoY) and the FY2025 annual result came in at $20.0 million, up 23.21% from the prior year.
  • Current Assets advanced to $80.1 million in Q1 2026 per IXHL's latest filing, from $74.7 million in the prior quarter.
  • Over the last five years, Current Assets for IXHL reached as high as $80.1 million in Q1 2026 and fell as low as $10.5 million in Q4 2024.
  • A 5-year average of $34.7 million and a median of $21.3 million in 2023 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2024 — Current Assets sank 50.76% — and 2025, when it soared 610.95%.
  • Year by year, Current Assets stood at $42.1 million in 2022, then slumped by 49.37% to $21.3 million in 2023, then plunged by 50.76% to $10.5 million in 2024, then surged by 610.95% to $74.7 million in 2025, then advanced by 7.25% to $80.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $80.1 million, $74.7 million, and $78.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 80.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.10 Mn
Dec 31, 2025 74.68 Mn
Sep 30, 2025 78.30 Mn
Jun 30, 2025 19.96 Mn
Mar 31, 2025 15.63 Mn
Dec 31, 2024 10.50 Mn
Sep 30, 2024 15.21 Mn
Jun 30, 2024 16.20 Mn
Mar 31, 2024 16.32 Mn
Dec 31, 2023 21.33 Mn
Jun 30, 2023 23.00 Mn
Dec 31, 2022 42.13 Mn
Jun 30, 2022 37.88 Mn
Jun 30, 2021 9.33 Mn
Jun 30, 2020 4.24 Mn